Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 1 1

Status

Unknown 5Completed 4Active not recruiting 2Terminated 1Recruiting 1Not yet recruiting 1

Sponsor Class

INDUSTRY 3OTHER 1

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Thoracic 3Other solid neoplasm 1

Conditions

Small Cell Lung Carcinoma 3Solid Tumors 1

Interventions

Cyclophosphamide 1492Cisplatin 1414Paclitaxel 1317Radiotherapy 1261Carboplatin 1250Gemcitabine 1215Docetaxel 1109Bevacizumab 1030Fluorouracil 894Doxorubicin 792Dexamethasone 748Rituximab 719Capecitabine 716Oxaliplatin 700pembrolizumab 680Etoposide 678Irinotecan 634Filgrastim 621Cytarabine 586Leucovorin 579Nivolumab 558Vincristine 515Prednisone 475Cetuximab 465Bortezomib 459Erlotinib Hydrochloride 456Trastuzumab 447Methotrexate 438Lenalidomide 427Pemetrexed 420

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Interventional × PE regimen × Clear all
NCT00878449 2018-06-06

A Study Evaluating the Safety of ABT-263 in Combination With Etoposide/Cisplatin in Subjects With Cancer

AbbVie

Phase 1 Completed
12 enrolled
Other solid neoplasm

Solid Tumors

NCT00658580 2015-02-12

Randomized Study of Cisplatin-Etoposide Versus an Etoposide Regimen Without Cisplatin in Extensive Small-Cell Lung Cancer

European Lung Cancer Working Party

Phase 3 Completed
361 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT00043927 2013-08-21

Extensive Small Cell Lung Cancer Treatment Using An Investigational Drug Plus Chemotherapy In Chemotherapy-Naive Adults

GlaxoSmithKline

Phase 3 Completed
760 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT00143455 2010-02-18

Study Of Irinotecan Hydrochloride (Campto(R)) And Cisplatin Versus Etoposide And Cisplatin In Small Cell Lung Cancer

Pfizer

Phase 3 Completed
485 enrolled 14 charts
Thoracic

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡